Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Obstructive Sleep Apnea in Patients with Congenital Long QT Syndrome: Implications for Increased Risk of Sudden Cardiac Death
Shamsuzzaman, Abu, Knilans, Timothy K. , Ackerman, Michael J. , Wang, Yu , Amin, Raouf , Shamsuzzaman, Abu S, Somers, Virend K.

Mayo Clinic

Sleep | June 30, 2015 | Volume: 38 | Issue: 7 | Pages: 1113-1119

10.5665/sleep.4824 | PMID 26118557 Get It

Treatment of medication-overuse headache: A systematic review
Chiang, Chia‐Chun , Schwedt, Todd J. , Wang, Shuu‐Jiun , Dodick, David W. , Chiang, Chia-Chun

Mayo Clinic

Cephalalgia | June 29, 2015 | Volume: 36 | Issue: 4 | Pages: 371-386

10.1177/0333102415593088 | PMID 26122645 Get It

Introduction The objective of this review is to provide an evidence-based discussion of different treatment strategies for medication-overuse headache (MOH). Method We searched PubMed for articles discussing the treatment and prognosis of MOH published between 2004 and August 2014. Titles, abstract and articles were reviewed systematically. The level of evidence provided by each study of the included articles was determined according to the American Academy of Neurology Clinical practice guideline manual. We discuss the level of evidence to support the early discontinuation/withdrawal of overused medications, the level of evidence to support the use of preventive treatment, the short- and long-term prognosis, and the outcome according to the class of drug overused in patients diagnosed with MOH. Results The initial search resulted in 1313 articles; 68 articles met our inclusion criteria and were discussed. The level of evidence to support early discontinuation of overused medications alone is low due to the absence of controlled studies. Adding preventive medication to early discontinuation led to a better outcome than early discontinuation alone. For patients with chronic migraine (CM) and medication overuse (MO), there are large randomized control trials supporting the use of onabotulinumtoxinA and topiramate without early discontinuation of overuse; however, the evidence is limited since data were obtained from post hoc analysis. Conclusion Considering current available evidence and the systemic toxicity of overusing acute headache medication, we suggest discontinuation of the overused medication with the addition of preventive medication. Appropriately sized, randomized controlled trials evaluating the safety and long-term efficacy of preventive medication plus early discontinuation of overuse vs preventive medication alone vs early discontinuation of overuse alone are needed.
Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study
Hein, Alexander , Lambrechts, Diether , Minckwitz, Gϋnter von, Häberle, Lothar , Eidtmann, Holger, Tesch, Hans , Hilfrich, J., Schem, Christian , Rezai, Mahdi , Gerber, Bernd, Costa, Serban Dan, Blohmer, Jens‐Uwe , Schwedler, Kathrin, Kittel, K., Fehm, Tanja , Kunz, Georg , Beckmann, Matthias W. , Ekici, Arif B. , Hanusch, Claus , Huober, Jens , Liedtke, Cornelia, Moisse, Matthieu , Müller, Volkmar , Nekljudova, Valentina , Peuteman, Gilian, Rack, Brigitte , Rübner, Matthias, Brussel, Thomas Van , Wang, Liewei , Weinshilboum, Richard M. , Loibl, Sibylle , Fasching, Peter A. , Lambrechts, Diether , Untch, Michael , Mau, Christine , Weinshilboum, Richard M. , Lambrechts, Diether , Hein, Alexander , Lambrechts, Diether , Ekici, Arif B , Moisse, Matthieu , Fehm, Tanja

Mayo Clinic

International Journal of Cancer | June 23, 2015 | Volume: 137 | Issue: 12 | Pages: 2981-2988

10.1002/ijc.29656 | PMID 26100253 Get It

Studies assessing the effect of bevacizumab (BEV) on breast cancer (BC) outcome have shown different effects on progression‐free and overall survival, suggesting that a subgroup of patients may benefit from this treatment. Unfortunately, no biomarkers exist to identify these patients. Here, we investigate whether single nucleotide polymorphisms (SNPs) in VEGF pathway genes correlate with pathological complete response (pCR) in the neoadjuvant GeparQuinto trial. HER2‐negative patients were randomized into treatment arms receiving either BEV combined with standard chemotherapy or chemotherapy alone. In a pre‐planned biomarker study, DNA was collected from 729 and 724 patients, respectively from both treatment arms, and genotyped for 125 SNPs. Logistic regression assessed interaction between individual SNPs and both treatment arms to predict pCR. Five SNPs may be associated with a better response to BEV, but none of them remained significant after correction for multiple testing. The two SNPs most strongly associated, rs833058 and rs699947, were located upstream of the VEGF‐A promoter. Odds ratios for the homozygous common, heterozygous and homozygous rare rs833058 genotypes were 2.36 (95% CI, 1.49–3.75), 1.20 (95% CI, 0.88–1.64) and 0.61 (95% CI, 0.34–1.12). Notably, some SNPs in VEGF‐A exhibited a more pronounced effect in the triple‐negative subgroup. Several SNPs in VEGF‐A may be associated with improved pCR when receiving BEV in the neoadjuvant setting. Although none of the observed effects survived correction for multiple testing, our observations are consistent with previous studies on BEV efficacy in BC. Further research is warranted to clarify the predictive value of these markers.
Global and local ancestry in African‐Americans: Implications for Alzheimer's disease risk
Hohman, Timothy J. , Bailey, Jessica N. Cooke , Reitz, Christiane , Jun, Gyungah , Beecham, Gary W. , Carney, Regina M., Vance, Jeffery M. , Rajbhandary, Ruchita, Lin, Chiao‐Feng , Larson, Eric B., Graff‐Radford, Neill R. , Evans, Denis A., Jager, Philip L. De , Crane, Paul K. , Buxbaum, Joseph D. , Murrell, Jill R. , Raj, Towfique , Ertekin‐Taner, Nilüfer , Baldwin, Clinton T., Green, Robert C. , Barnes, Lisa L. , Cantwell, Laura B., Fallin, M. Daniele , Go, Rodney C.P., Griffith, Patrick , Obisesan, Thomas O. , Lunetta, Kathryn L. , Kamboh, M. Ilyas , Bennett, David A. , Hardy, John , Hendrie, Hugh C. , Hall, Kathleen, Goate, Alison , Lang, Rosalyn, Byrd, Goldie S. , Kukull, Walter A. , Farrer, Lindsay A. , Martin, Eden R. , Pericak‐Vance, Margaret A. , Schellenberg, Gerard D. , Mayeux, Richard , Haines, Jonathan L. , Thornton‐Wells, Tricia A., Carroll, Steven L. , Bennett, David A. , Naj, Adam Christian , Liu, Zhi , Cuccaro, Michael L. , Vardarajan, Badri Narayan , Wang, Weixin , Valladares, Otto , Logue, Mark W. , Manly, Jennifer J. , López, Oscar L. , Foroud, Tatiana , Seto, Mabel , Hardy, John , Goate, Alison M , Barnes, Lisa L

Mayo Clinic

Alzheimer's & Dementia | June 16, 2015 | Volume: 12 | Issue: 3 | Pages: 233-243

10.1016/j.jalz.2015.02.012 | PMID 26092349 Get It

AbstractIntroductionAfrican‐American (AA) individuals have a higher risk for late‐onset Alzheimer's disease (LOAD) than Americans of primarily European ancestry (EA). Recently, the largest genome‐wide association study in AAs to date confirmed that six of the Alzheimer's disease (AD)‐related genetic variants originally discovered in EA cohorts are also risk variants in AA; however, the risk attributable to many of the loci (e.g., APOE, ABCA7) differed substantially from previous studies in EA. There likely are risk variants of higher frequency in AAs that have not been discovered.MethodsWe performed a comprehensive analysis of genetically determined local and global ancestry in AAs with regard to LOAD status.ResultsCompared to controls, LOAD cases showed higher levels of African ancestry, both globally and at several LOAD relevant loci, which explained risk for AD beyond global differences.DiscussionExploratory post hoc analyses highlight regions with greatest differences in ancestry as potential candidate regions for future genetic analyses.
Causes and Prognosis of Visual Acuity Loss at the Time of Initial Presentation in Idiopathic Intracranial Hypertension
Chen, John J. , Thurtell, Matthew J. , Longmuir, Reid, Garvin, Mona K. , Wang, Jui-Kai, Wall, Michael , Kardon, Randy H. , Wang, Jui-Kai , Chen, John J

Mayo Clinic

Investigative Opthalmology & Visual Science | June 12, 2015 | Volume: 56 | Issue: 6 | Pages: 3850

10.1167/iovs.15-16450 | PMID 26070058 Get It

197 Left Atrial Remodelling and Atrioventricular Coupling in a Canine Model of Early Heart Failure with Preserved Ejection Fraction
Chai, Qiang , Ogut, Ozgur, Takahama, Hiroyuki , Wang, Xiaoli , Lee, Hon-Chi , Redfield, Margaret M. , Zakeri, Rosita , Moulay, Gilles , Chai, Qiang, Hussain, Saad Abdulrahman , Lü, Tong , Linke, Wolfgang A.

Mayo Clinic

Basic Science | June 6, 2015 | Volume: No volume available | Issue: No issue available | Pages: A109.2-A110

10.1136/heartjnl-2015-308066.197 Get It

Fluorescence in situ hybridization identifies high risk Barrett's patients likely to develop esophageal adenocarcinoma
Brankley, Shannon M., Halling, Kevin C. , Jenkins, Sarah M. , Timmer, Margriet R., Iyer, Prasad G. , Smyrk, Thomas C. , Voss, Jesse S. , Kipp, Benjamin R. , Campion, Michael B., Lutzke, Lori S., Minot, Douglas M., Wang, K. K., Fritcher, Emily G. Barr , Wang, Kenneth K

Mayo Clinic

Diseases of the Esophagus | June 5, 2015 | Volume: 29 | Issue: 6 | Pages: 513-519

10.1111/dote.12372 | PMID 26043762 Get It

A Large Multiethnic Genome-Wide Association Study of Prostate Cancer Identifies Novel Risk Variants and Substantial Ethnic Differences
Hoffmann, Thomas J. , Jorgenson, Eric , Habel, Laurel A. , Passarelli, Michael N. , Cario, Clinton L. , Emami, Nima C. , Chao, Chun , Ghai, Nirupa R. , Shan, Jun , Ranatunga, Dilrini K., Aaronson, David S., Presti, Joseph C. , Berndt, Sonja I. , McDonnell, Shannon K. , French, Amy J. , Schaid, Daniel J. , Thibodeau, Stephen N. , Freedman, Matthew L. , Mucci, Lorelei A. , Haiman, Christopher A. , Henderson, Brian E., Seminara, Daniela, Kvale, Mark , Schaefer, Catherine , Risch, Neil , Witte, John S. , Wang, Zhaoming , Van Den Eeden, Stephen K , Sakoda, Lori C. , Graff, Rebecca E. , Quesenberry, Charles P. , Wang, Zhaoming , Chanock, Stephen Jacob , Li, Qiyuan , Penney, Kathryn , Kwok, Pui–Yan , Wang, Zhaoming , McDonnell, Shannon K

Mayo Clinic

Cancer Discovery | June 2, 2015 | Volume: 5 | Issue: 8 | Pages: 878-891

10.1158/2159-8290.cd-15-0315 | PMID 26034056 Get It

Abstract A genome-wide association study (GWAS) of prostate cancer in Kaiser Permanente health plan members (7,783 cases, 38,595 controls; 80.3% non-Hispanic white, 4.9% African-American, 7.0% East Asian, and 7.8% Latino) revealed a new independent risk indel rs4646284 at the previously identified locus 6q25.3 that replicated in PEGASUS (N = 7,539) and the Multiethnic Cohort (N = 4,679) with an overall P = 1.0 × 10−19 (OR, 1.18). Across the 6q25.3 locus, rs4646284 exhibited the strongest association with expression of SLC22A1 (P = 1.3 × 10−23) and SLC22A3 (P = 3.2 × 10−52). At the known 19q13.33 locus, rs2659124 (P = 1.3 × 10−13; OR, 1.18) nominally replicated in PEGASUS. A risk score of 105 known risk SNPs was strongly associated with prostate cancer (P < 1.0 × 10−8). Comparing the highest to lowest risk score deciles, the OR was 6.22 for non-Hispanic whites, 5.82 for Latinos, 3.77 for African-Americans, and 3.38 for East Asians. In non-Hispanic whites, the 105 risk SNPs explained approximately 7.6% of disease heritability. The entire GWAS array explained approximately 33.4% of heritability, with a 4.3-fold enrichment within DNaseI hypersensitivity sites (P = 0.004). Significance: Taken together, our findings of independent risk variants, ethnic variation in existing SNP replication, and remaining unexplained heritability have important implications for further clarifying the genetic risk of prostate cancer. Our findings also suggest that there may be much promise in evaluating understudied variation, such as indels and ethnically diverse populations. Cancer Discov; 5(8); 878–91. ©2015 AACR. This article is highlighted in the In This Issue feature, p. 783
Multi-Institutional Validation of an OSATS for the Assessment of Cystoscopic and Ureteroscopic Skills
Argun, Ömer Burak , Chrouser, Kristin , Chauhan, Sanket, Monga, Manoj, Knudsen, Bodo E. , Box, Geoffrey N., Lee, David I. , Gettman, Matthew T., Poniatowski, Lauren H. , Wang, Qi , Reihsen, Troy, Sweet, Robert

Mayo Clinic

Journal of Urology | May 27, 2015 | Volume: 194 | Issue: 4 | Pages: 1098-1106

10.1016/j.juro.2015.02.2959 | PMID 26025502 Get It

Retraction: N, S co-doped graphene quantum dots from a single source precursor used for photodynamic cancer therapy under two-photon excitation
Liu, Xifeng , Xia, Jianfei , Bi, Sai , Xia, Yanzhi, Gui, Rijun , Jin, Hui , Wang, Zonghua , Zhang, Feifei , Yang, Min Jae , Xia, Yanzhi

Mayo Clinic

Chemical Communications | May 26, 2015 | Volume: 51 | Issue: 49 | Pages: 10066-10066

10.1039/c5cc90244d | PMID 26008806 Get It

Retraction of ‘N, S co-doped graphene quantum dots from a single source precursor used for photodynamic cancer therapy under two-photon excitation’ by Rijun Gui et al. , Chem. Commun ., DOI: 10.1039/C4CC09280E.